E Lindner

445 total citations
24 papers, 218 citations indexed

About

E Lindner is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, E Lindner has authored 24 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Molecular Biology and 6 papers in Organic Chemistry. Recurrent topics in E Lindner's work include Pharmacogenetics and Drug Metabolism (4 papers), Pharmacological Effects of Natural Compounds (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). E Lindner is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Pharmacological Effects of Natural Compounds (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). E Lindner collaborates with scholars based in Germany, Jordan and Austria. E Lindner's co-authors include A N Dohadwalla, B. K. Bhattacharya, H Metzger, O. Schaumann, Hermann J. Gerhards, Hans Wissmann, Rolf Geiger, Bernward A. Schoelkens, Jason Chin and Rawand Abdin and has published in prestigious journals such as Cellular and Molecular Life Sciences, Journal of Molecular Medicine and Naunyn-Schmiedeberg s Archives of Pharmacology.

In The Last Decade

E Lindner

23 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Lindner Germany 9 93 47 33 31 29 24 218
G. Nell Germany 13 130 1.4× 43 0.9× 32 1.0× 17 0.5× 34 1.2× 30 382
Hideto Miyazaki Japan 10 140 1.5× 42 0.9× 54 1.6× 19 0.6× 21 0.7× 24 365
Roscoe M. Hersey United States 11 105 1.1× 19 0.4× 16 0.5× 50 1.6× 15 0.5× 14 354
P. Braquet France 13 103 1.1× 78 1.7× 33 1.0× 8 0.3× 77 2.7× 44 357
Toshio Yoshizaki Japan 12 128 1.4× 44 0.9× 99 3.0× 61 2.0× 11 0.4× 27 392
Richard D. Howland United States 11 85 0.9× 32 0.7× 29 0.9× 50 1.6× 10 0.3× 17 354
Lyle V. Beck United States 9 110 1.2× 71 1.5× 13 0.4× 35 1.1× 15 0.5× 25 328
Jean Rabovsky United States 7 98 1.1× 36 0.8× 30 0.9× 27 0.9× 17 0.6× 22 322
Dusit Jirakulsomchok United States 11 80 0.9× 111 2.4× 50 1.5× 19 0.6× 38 1.3× 36 378
Victoria Villagrasa Spain 10 169 1.8× 86 1.8× 38 1.2× 30 1.0× 15 0.5× 18 364

Countries citing papers authored by E Lindner

Since Specialization
Citations

This map shows the geographic impact of E Lindner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Lindner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Lindner more than expected).

Fields of papers citing papers by E Lindner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Lindner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Lindner. The network helps show where E Lindner may publish in the future.

Co-authorship network of co-authors of E Lindner

This figure shows the co-authorship network connecting the top 25 collaborators of E Lindner. A scholar is included among the top collaborators of E Lindner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Lindner. E Lindner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lindner, E, et al.. (2025). Is Milk Thistle a Cardioprotective Ally or a Thrombotic Threat?. JACC Case Reports. 30(28). 104999–104999.
2.
Li, Ben, E Lindner, Farah Shaikh, et al.. (2025). Interferon Gamma and Tumor Necrosis Factor Alpha Are Inflammatory Biomarkers for Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease. Biomedicines. 13(7). 1586–1586. 1 indexed citations
3.
Lindner, E. (1990). Toxikologie der Nahrungsmittel.. Medical Entomology and Zoology. 12 indexed citations
4.
Lindner, E, et al.. (1984). Hoe 263, a New Substance with Calcium Channel Antagonistic Activity. Pharmacology. 29(3). 165–172. 1 indexed citations
5.
Lindner, E, et al.. (1984). Perfluorochemical Perfusion of the Isolated Guinea Pig Heart. Pharmacology. 28(6). 336–342. 7 indexed citations
6.
Lindner, E & H Metzger. (1983). The action of forskolin on muscle cells is modified by hormones, calcium ions and calcium antagonists.. PubMed. 33(10). 1436–41. 18 indexed citations
7.
8.
Lindner, E, et al.. (1982). Diphasic action of 2,2-diphenylpropionic acid N,N-diethylaminoethyl ester hydrochloride on hepatic drug metabolism in the mouse. Cellular and Molecular Life Sciences. 38(10). 1220–1222. 3 indexed citations
9.
Lindner, E, A N Dohadwalla, & B. K. Bhattacharya. (1978). Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohli: Forskolin.. PubMed. 28(2). 284–9. 68 indexed citations
10.
Lindner, E, et al.. (1976). Diphasic action of the aliphatic amide, HOE 17879, on hepatic microsomal drug metabolizing enzymes in the mouse. Cellular and Molecular Life Sciences. 32(3). 362–365. 10 indexed citations
11.
Wissmann, Hans, Bernward A. Schoelkens, E Lindner, & Rolf Geiger. (1974). Chemie und Wirkungsweise neuer Angiotensin-II-Antagonisten. 8-C-Phenylglycin-Analoga des [5-Isoleucin]Angiotensins II. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 355(2). 1083–1096. 2 indexed citations
12.
Gerhards, Hermann J., et al.. (1974). Circulatory effects of intravenously administered rolitetracycline and other tetracyclines in animal experiments.. PubMed. 24(3). 312–7. 3 indexed citations
13.
Lindner, E, et al.. (1974). ACTH and alpha-MSH: cardiovascular and antiarrhythmic properties.. PubMed. 208(1). 19–23. 10 indexed citations
14.
Lindner, E. (1963). [INVESTIGATION ON THE BEHAVIOR OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN) AGAINST THE ACTION OF NORADRENALINE].. PubMed. 146. 475–84. 1 indexed citations
15.
Lindner, E. (1963). [RESEARCH ON THE ANTIFIBRILLATORY ACTION OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN)].. PubMed. 146. 485–500. 6 indexed citations
16.
Lindner, E, et al.. (1962). �ber die Wirkung von N-(3?-Phenyl-propyl-(2?))-1,1-diphenyl-propyl-(3)-amin auf den Katecholamin-Stoffwechsel. Journal of Molecular Medicine. 40(23). 1196–1200. 30 indexed citations
17.
Lindner, E. (1961). [The effect of 3,3-diphenyl-N-(alpha-methyl-phenethyl)-propylamine on myocardial metabolism].. PubMed. 27. 256–9. 2 indexed citations
18.
Lindner, E, et al.. (1959). [Derivatives of diphenyl-piperidino-propane, a new series of antitussive agents].. PubMed. 9(2). 94–9. 2 indexed citations
19.
Lindner, E, et al.. (1958). Untersuchungen �ber die Anaesthesie der Dehnungs- und Ber�hrungsreceptoren durch einige Lokalanaesthetica im Vergleich zur hustenstillenden Wirkung. Naunyn-Schmiedeberg s Archives of Pharmacology. 234(2). 164–178. 11 indexed citations
20.
Schaumann, O. & E Lindner. (1951). Neue synthetische Verbindungen der ?Polamidonreihe? mit parasympathicolytischer Wirkung. Naunyn-Schmiedeberg s Archives of Pharmacology. 214(1). 93–102. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Nell Breakdown of academic impact, for papers by Hideto Miyazaki Breakdown of academic impact, for papers by Roscoe M. Hersey Breakdown of academic impact, for papers by P. Braquet Breakdown of academic impact, for papers by Toshio Yoshizaki Breakdown of academic impact, for papers by Richard D. Howland Breakdown of academic impact, for papers by Lyle V. Beck Breakdown of academic impact, for papers by Jean Rabovsky Breakdown of academic impact, for papers by Dusit Jirakulsomchok Breakdown of academic impact, for papers by Victoria Villagrasa
Rankless by CCL
2026